Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate and Ibritumomab
Determining the interaction of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate and Ibritumomab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: efavirenz / emtricitabine / tenofovir
Brand name: Atripla
Synonyms: Efavirenz, emtricitabine, and tenofovir
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab Tiuxetan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate-Ibritumomab Intravenous
- Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate-Ibritumomab Tiuxetan
- Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate-Ibrutinib
- Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate-Ibrutinib Capsules
- Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate-Ibrutinib Tablets
- Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate-Ibu
- Ibritumomab-Efavirenz, lamivudine, and tenofovir
- Ibritumomab-Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate
- Ibritumomab-Effaclor Duo
- Ibritumomab-Effer-K
- Ibritumomab-Effer-K Tablets
- Ibritumomab-Effervescent Potassium